FY18 results were as expected, with revenues up and losses narrowed despite the slow commercialisation cycle in display. FY19 will be a year of laying foundations to ready the facilities for volume production in nanomaterials, but we expect a doubling of revenues nonetheless. The move to volume production should support a further inflection in FY20.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.